The potential of imaging techniques as a screening tool for colorectal cancer: A cost-effectiveness analysis

British Journal of Radiology

Volumn 89, Issue 1063, 2016, Pages

  Greuter, Marjolein J E ^a   Berkhof, Johannes ^a   Fijneman, Remond J A ^b   Demirel, Erhan ^a   Lew, Jie Bin ^c   Meijer, Gerrit A ^b   Stoker, Jaap ^a   Couṕe, Veerle M H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c CANCER RESEARCH DIVISION   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SCREENING; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; INTESTINE RADIOGRAPHY; MAGNETIC RESONANCE COLONOGRAPHY; MALE; COLON; COLORECTAL TUMOR; COST BENEFIT ANALYSIS; DIAGNOSTIC IMAGING; ECONOMICS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; RECTUM; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLON; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLORECTAL NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECTUM;

EID: 84989315828     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20150910     Document Type: Article

References (59)

1. International Agency for Research on Cancer. GLOBOCAN 2012 [Updated 2012; cited 25 March 2014]. Available from: http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx
2. Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 2013;369:1106-14. doi: http://dx.doi.org/10.1056/NEJMoa1300720
3. Elmunzer BJ, Hayward RA, Schoenfeld PS, Saini SD, Deshpande A, Waljee AK. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. Plos Med 2012;9:e1001352. doi: http://dx.doi.org/10.1371/journal.pmed.1001352
4. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, Van Ballegooijen M, Hankey BF, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687-96. doi: http://dx.doi.org/10.1056/NEJMoa1100370
5. International Agency for Research on Cancer. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. First Report. 2008.
6. U. S. Preventive Services Task Force. Screening for Colorectal Cancer [Updated 2008; cited September 2014]. Available from: www.uspreventiveservicetaskforce.org/uspst/uspcolo.htm
7. Harewood GC, Wiersema MJ, Melton LJ 3rd. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002;97:3186-94. doi: http://dx.doi.org/10.1111/j.1572-0241.2002.07129.x
8. Jones RM, Devers KJ, Kuzel AJ, Woolf SH. Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med 2010;38:508-16. doi: http://dx.doi.org/10.1016/j.amepre. 2010.01.021
9. Liedenbaum MH, Denters MJ, Zijta FM, Van Ravesteijn VF, Bipat S, Vos FM, et al. Reducing the oral contrast dose in CT colonography: evaluation of faecal tagging quality and patient acceptance. Clin Radiol 2011;66:30-7. doi: http://dx.doi.org/10.1016/j.crad.2010.06.016
10. Liedenbaum MH, De Vries AH, Gouw CI, Van Rijn AF, Bipat S, Dekker E, et al. CT colonography with minimal bowel preparation: evaluation of tagging quality, patient acceptance and diagnostic accuracy in two iodine-based preparation schemes. Eur Radiol 2010;20:367-76. doi: http://dx.doi.org/10.1007/s00330-009-1570-8
11. Lin OS, Kozarek RA, Gluck M, Jiranek GC, Koch J, Kowdley KV, et al. Preference for colonoscopy versus computerized tomographic colonography: a systematic review and meta-analysis of observational studies. J Gen Intern Med 2012;27:1349-60. doi: http://dx.doi.org/10.1007/s11606-012-2115-4
12. Stoop EM, De Haan MC, De Wijkerslooth TR, Bossuyt PM, Van Ballegooijen M, Nio CY, et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 2012;13:55-64. doi: http://dx.doi.org/10.1016/S1470-2045 (11) 70283-2
13. Johnson CD, Chen MH, Toledano AY, Heiken JP, Dachman A, Kuo MD, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:1207-17. doi: http://dx.doi.org/10.1056/NEJMoa0800996
14. Chaparro M, Gisbert JP, Del Campo L, Cantero J, Maté J. Accuracy of computed tomographic colonography for the detection of polyps and colorectal tumors: a systematic review and meta-analysis. Digestion 2009;80:1-17. doi: http://dx.doi.org/10.1159/000215387
15. Rosman AS, Korsten MA. Meta-analysis comparing CT colonography, air contrast barium enema, and colonoscopy. Am J Med 2007;120:203-10. e4. doi: http://dx.doi.org/10.1016/j.amjmed.2006.05.061
16. Pickhardt PJ, Hassan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and colonoscopy for detection-systematic review and meta-analysis. Radiology 2011;259:393-405. doi: http://dx.doi.org/10.1148/radiol.11101887
17. De Haan MC, Van Gelder RE, Graser A, Bipat S, Stoker J. Diagnostic value of CTcolonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis. Eur Radiol 2011;21:1747-63. doi: http://dx.doi.org/10.1007/s00330-011-2104-8
18. Hartmann D, Bassler B, Schilling D, Adamek HE, Jakobs R, Pfeifer B, et al. Colorectal polyps: detection with dark-lumen MR colonography versus conventional colonoscopy. Radiology 2006;238:143-9. doi: http://dx.doi.org/10.1148/radiol.2381041756
19. Kuehle CA, Langhorst J, Ladd SC, Zoepf T, Nuefer M, Grabellus F, et al. Magnetic resonance colonography without bowel cleansing: a prospective cross sectional study in a screening population. Gut 2007;56:1079-85. doi: http://dx.doi.org/10.1136/gut.2006.109306
20. Graser A, Melzer A, Lindner E, Nagel D, Herrmann K, Stieber P, et al. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults. Gastroenterology 2013;144:743-50. e2. doi: http://dx.doi.org/10.1053/j. gastro.2012.12.041
21. Zijta FM, Bipat S, Stoker J. Magnetic resonance (MR) colonography in the detection of colorectal lesions: a systematic review of prospective studies. Eur Radiol 2010;20:1031-46. doi: http://dx.doi.org/10.1007/s00330-009-1663-4
22. Kinner S, Kuehle CA, Langhorst J, Ladd SC, Nuefer M, Zoepf T, et al. MR colonography vs. optical colonoscopy: comparison of patients' acceptance in a screening population. Eur Radiol 2007;17:2286-93. doi: http://dx.doi.org/10.1007/s00330-007-0643-9
23. Florie J, Birnie E, Van Gelder RE, Jensch S, Haberkorn B, Bartelsman JF, et al. MR colonography with limited bowel preparation: patient acceptance compared with that of full-preparation colonoscopy. Radiology 2007;245:150-9. doi: http://dx.doi.org/10.1148/radiol.2451061244
24. Van Der Paardt MP, Stoker J. Magnetic resonance colonography for screening and diagnosis of colorectal cancer. Magn Reson Imaging Clin N Am 2014;22:67-83. doi: http://dx.doi.org/10.1016/j.mric.2013.07.006
25. Van Der Paardt MP, Boellaard TN, Zijta FM, Baak LC, Depla AC, Dekker E, et al. Magnetic resonance colonography with a limited bowel preparation and automated carbon dioxide insufflation in comparison to conventional colonoscopy: patient burden and preferences. Eur J Radiol 2015;84:19-25. doi: http://dx. doi.org/10.1016/j.ejrad.2014.10.006
26. Greuter MJ, Xu XM, Lew JB, Dekker E, Kuipers EJ, Canfell K, et al. Modeling the Adenoma and Serrated pathway to Colorectal Cancer (ASCCA). Risk Anal 2014;34:889-910. doi: http://dx.doi.org/10.1111/risa.12137
27. Greuter MJ, Demirel E, Lew JB, Berkhof J, Xu XM, Canfell K, et al. Long-term impact of the Dutch colorectal cancer screening program on cancer incidence and mortality-modelbased exploration of the serrated pathway. Cancer Epidemiol Biomarkers Prev 2016;25:135-44. doi: http://dx.doi.org/10.1158/1055-9965. EPI-15-0592
28. Winawer SJ, Zauber AG. The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am 2002;12:1-9, v. doi: http://dx.doi.org/10.1016/S1052-5157 (03) 00053-9
29. IKNL. Cijfers over kanker [Updated 2011; cited 2013 Feb]. Available from: http://www.cijfersoverkanker.nl
30. Kapidzic A, Grobbee EJ, Hol L, Van Roon AH, Van Vuuren AJ, Spijker W, et al. Attendance and yield over three rounds of population-based fecal immunochemical test screening. Am J Gastroenterol 2014;109:1257-64. doi: http://dx.doi.org/10.1038/ajg.2014.168
31. Van Roon AH, Goede SL, Van Ballegooijen M, Van Vuuren AJ, Looman CW, Biermann K, et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut 2013;62:409-15. doi: http://dx.doi.org/10.1136/gutjnl-2011-301583
32. Nederlandse Vereniging van Maag-, Darmen Leverartsen. Nederlandse Richtlijn Coloscopie Surveillance; 2013.
33. Mulhall BP, Veerappan GR, Jackson JL. Metaanalysis: computed tomographic colonography. Ann Intern Med 2005;142:635-50. doi: http://dx.doi.org/10.7326/0003-4819-142-8-200504190-00013
34. Van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, Van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006;101:343-50. doi: http://dx.doi.org/10.1111/j.1572-0241.2006.00390.x
35. Van Rossum LG, Van Rijn AF, Laheij RJ, Van Oijen MG, Fockens P, Van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90. doi: http://dx.doi.org/10.1053/j.gastro.2008.03.040
36. Central Bureau for Statistics [Updated 2015; cited 2015 May]. Available from: http://www.cbs.nl
37. Atalla MA, Rozen WM, Niewiadomski OD, Croxford MA, Cheung W, Ho YH. Risk factors for colonic perforation after screening computed tomographic colonography: a multicentre analysis and review of the literature. J Med Screen 2010;17:99-102. doi: http://dx.doi.org/10.1258/jms.2010.010042
38. Lüning TH, Keemers-Gels ME, Barendregt WB, Tan AC, Rosman C. Colonoscopic perforations: a review of 30, 366 patients. Surg Endosc 2007;21:994-7. doi: http://dx.doi.org/10.1007/s00464-007-9251-7
39. Siegel JE, Torrance GW, Russell LB, Luce BR, Weinstein MC, Gold MR. Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in health and medicine. PharmacoEconomics 1997;11:159-68. doi: http://dx. doi.org/10.2165/00019053-199711020-00005
40. WHO. WHO-CHOICE: WHO [Updated 2013; cited 2014 Jan]. Available from: http://www.who.int/choice/en
41. Final Update Summary: Colorectal Cancer: Screening-US Preventive Services Task Force. [Updated 2015; cited 2016 April 22]. Available from: http://www.uspreventiveservicestaskforce.org/Page/Document/Update-SummaryFinal/colorectal-cancer-screening
42. Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev 2011;33:88-100. doi: http://dx.doi.org/10.1093/epirev/mxr004
43. Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, et al. Colorectal cancer screening: a global overview of existing programmes. Gut 2015;64:1637-49. doi: http://dx.doi.org/10.1136/gutjnl-2014-309086
44. De Wijkerslooth TR, De Haan MC, Stoop EM, Bossuyt PM, Thomeer M, Essink-Bot ML, et al. Burden of colonoscopy compared to non-cathartic CT-colonography in a colorectal cancer screening programme: randomised controlled trial. Gut 2012;61:1552-9. doi: http://dx.doi.org/10.1136/gutjnl-2011-301308
45. Rockey DC. Computed tomographic and magnetic resonance colonography: challenge for colonoscopy. Dig Dis 2012;30(Suppl. 2):60-7. doi: http://dx.doi.org/10.1159/000341895
46. Rijksinstituut voor Volksgezondheid en Milieu. Factsheet Bevolkingsonderzoek Darmkanker; 2015.
47. D'Hauwers KW, Gadet PF, Donders AR, Tjalma W. Impact of medical education on knowledge and attitudes regarding the human papilloma virus and vaccination: comparison before and 6 years after the introduction of the vaccines. Vaccine 2013;31:5843-7. doi: http://dx.doi.org/10.1016/j. vaccine.2013.09.068
48. Rijksinstituut voor Volksgezondheid en Milieu. Bevolkingsonderzoek darmkanker [Updated 2013; cited 2014 April 28]. Available from: http://www.rivm.nl/Onderwerpen/B/Bevolkingsonderzoek-darmkanker
49. De Haan MC, Halligan S, Stoker J. Does CT colonography have a role for populationbased colorectal cancer screening? Eur Radiol 2012;22:1495-503. doi: http://dx.doi.org/10.1007/s00330-012-2449-7
50. Tilson L, Sharp L, Usher C, Walsh C, Whyte S, O'Ceilleachair A, et al. Cost of care for colorectal cancer in Ireland: a health care payer perspective. Eur J Health Econ 2012;13:511-24. doi: http://dx.doi.org/10.1007/s10198-011-0325-z
51. Ferlitsch M, Reinhart K, Pramhas S, Wiener C, Gal O, Bannert C, et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA 2011;306:1352-8. doi: http://dx.doi.org/10.1001/jama.2011.1362
52. Bokemeyer B, Bock H, Hüppe D, Duffelmeyer M, Rambow A, Tacke W, et al. Screening colonoscopy for colorectal cancer prevention: results from a German online registry on 269000 cases. Eur J Gastroenterol Hepatol 2009;21:650-5. doi: http://dx.doi.org/10.1097/MEG. 0b013e32830b8acf
53. Boursi B, Halak A, Umansky M, Galzan L, Guzner-Gur H, Arber N. Colonoscopic screening of an average-risk population for colorectal neoplasia. Endoscopy 2009;41:516-21. doi: http://dx.doi.org/10.1055/s-0029-1214757
54. Mapp TJ, Hardcastle JD, Moss SM, Robinson MHE. Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening. Br J Surg 1999;86:1286-91. doi: http://dx.doi.org/10.1046/j.1365-2168.1999.01229.x
55. De Haan MC, Thomeer M, Stoker J, Dekker E, Kuipers EJ, Van Ballegooijen M. Unit costs in population-based colorectal cancer screening using CT colonography performed in university hospitals in Netherlands. Eur Radiol 2013;23:897-907. doi: http://dx.doi.org/10.1007/s00330-012-2689-6
56. Nederlandse Zorgautoriteit [Updated 2013; cited 2013 May]. Available from: www.nza.nl/regelgeving/tarieven
57. Stoop E, De Wijkerslooth T, Bossuyt FF, Van Leerdam ME, Stoker J. The colonoscopy unit costs of population-based screening for colorectal cancer. In submission.
58. Health Council of Netherlands. Population Screening Act: national population screening programme for bowel cancer. The Hague: Health Council of Netherlands; 2009: Publication no. 2009.13.
59. Rex DK, Petrini JL, Baron TH, Chak A, Cohen J, Deal SE, et al. Quality indicators for colonoscopy. Gastrointest Endosc 2006;63(Suppl. 4):S16-28. doi: http://dx.doi.org/10.1016/j.gie.2006.02.021